{"id":513080,"date":"2025-11-05T08:15:13","date_gmt":"2025-11-05T08:15:13","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/513080\/"},"modified":"2025-11-05T08:15:13","modified_gmt":"2025-11-05T08:15:13","slug":"sur-la-piste-dune-molecule-contre-les-redoutables-neuropathies-provoquees-par-la-chimiotherapie","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/513080\/","title":{"rendered":"sur la piste d\u2019une mol\u00e9cule contre les redoutables neuropathies provoqu\u00e9es par la chimioth\u00e9rapie"},"content":{"rendered":"<p>    Les neuropathies chimio-induites sont provoqu\u00e9es par une atteinte des nerfs, qui se traduit principalement dans les pieds et les mains par des sensations d\u00e9sagr\u00e9ables (engourdissements, fourmillement, picotements&#8230;) et\/ou des douleurs (br\u00fblures, d\u00e9charges \u00e9lectriques&#8230;).<br \/>\n                Khunatorn &#8211; stock.adobe.com<\/p>\n<p>\n    Une \u00e9quipe fran\u00e7aise a d\u00e9couvert une mol\u00e9cule permettant de prot\u00e9ger les nerfs p\u00e9riph\u00e9riques en cause dans cet effet ind\u00e9sirable majeur des traitements anticancer.<\/p>\n<p class=\"fig-paragraph\">\u00ab\u00a0Tu as trouv\u00e9 le graal\u00a0!\u00a0\u00bb, a lanc\u00e9 un jour cette chercheuse am\u00e9ricaine \u00e0 sa cons\u0153ur fran\u00e7aise. Francesca Bartolini, biologiste \u00e0 l\u2019Universit\u00e9 de Columbia (New York), venait de tester sur des neurones une mol\u00e9cule d\u00e9busqu\u00e9e par Laurence Lafanech\u00e8re, directrice de recherche CNRS \u00e0 l\u2019Institut pour l\u2019avanc\u00e9e des biosciences, \u00e0 Grenoble. Et la substance promettait d\u2019\u00eatre efficace contre un\u00a0<a href=\"https:\/\/www.lefigaro.fr\/sciences\/non-la-chimiotherapie-n-est-pas-toujours-un-enfer-pave-d-effets-indesirables-20220321\" data-fig-type=\"Article\" data-gtm-custom-categorie=\"navigation\" data-gtm-custom-action=\"crossclick\" data-gtm-custom-label=\"Contextuel\" data-gtm-event=\"customEventSPE\" data-fig-domain=\"LEFIGARO\" target=\"_blank\" rel=\"noopener\">effet secondaire majeur de certaines chimioth\u00e9rapies<\/a>\u00a0: les\u00a0<a href=\"http:\/\/sante.lefigaro.fr\/medecine\/brulures-fourmillements-decharges-electriques-les-douleurs-neuropathiques-des-crises-de-nerfs-au-sens-propre-du-terme-20250927\" data-fig-type=\"Article\" data-gtm-custom-categorie=\"navigation\" data-gtm-custom-action=\"crossclick\" data-gtm-custom-label=\"Contextuel\" data-gtm-event=\"customEventSPE\" data-fig-domain=\"SANTE\" target=\"_blank\" rel=\"noopener\">neuropathies<\/a>\u00a0chimio-induites, une atteinte des nerfs p\u00e9riph\u00e9rique douloureuse, handicapante, pouvant durer des ann\u00e9es apr\u00e8s la fin du traitement, et contre lesquelles la m\u00e9decine est actuellement d\u00e9munie.<\/p>\n<p class=\"fig-paragraph\">Naus\u00e9es et vomissements, aphtes, risques d\u2019infection, fatigue&#8230; Chacun conna\u00eet le cort\u00e8ge des effets ind\u00e9sirables possibles de\u00a0<a href=\"https:\/\/www.lefigaro.fr\/sciences\/cancers-la-revolution-en-marche-20221113\" data-fig-type=\"Article\" data-gtm-custom-categorie=\"navigation\" data-gtm-custom-action=\"crossclick\" data-gtm-custom-label=\"Contextuel\" data-gtm-event=\"customEventSPE\" data-fig-domain=\"LEFIGARO\" target=\"_blank\" rel=\"noopener\">la chimioth\u00e9rapie anticancer<\/a>. Mais ils s\u2019arr\u00eatent \u00e0 la fin du traitement et, surtout, il existe d\u00e9sormais des armes efficaces pour les limiter. Ce n\u2019est pas le cas des neuropathies p\u00e9riph\u00e9riques, une atteinte\u2026<\/p>\n<p class=\"fig-premium-paywall__infos\">\n        Cet article est r\u00e9serv\u00e9 aux abonn\u00e9s.        Il vous reste 84% \u00e0 d\u00e9couvrir.\n    <\/p>\n<p>                <img  data- alt=\"Le Figaro\" class=\"fig-img--complete fig-img\"\/><\/p>\n<p class=\"fig-premium-paywall__title\">Vous avez envie de lire la suite ?<\/p>\n<p class=\"fig-premium-paywall__subtitle\">D\u00e9bloquez tous les articles imm\u00e9diatement.<\/p>\n<p class=\"fig-premium-paywall__connect\">\n                D\u00e9j\u00e0 abonn\u00e9\u00a0?                <a class=\"fig-premium-paywall__connect-link\" href=\"https:\/\/connect.lefigaro.fr\/login?client=sante_web&amp;type=main&amp;redirect_uri=https%3A%2F%2Fsante.lefigaro.fr%2Fmedecine%2Fcancer-sur-la-piste-d-une-molecule-contre-les-redoutables-neuropathies-provoquees-par-la-chimiotherapie-20251105%3Ftblci%3DGiA7wq5eVkYk1FS9buemA3Y0BTZnnHNq1VcvNyXM79GA6CC-0lYos5zSwomrnbPOAQ\" data-js-gtm=\"{&quot;customCategorie&quot;: &quot;conversion&quot;, &quot;customAction&quot;: &quot;before_Landing_Connexion_paywall_auto&quot;, &quot;customLabel&quot;: &quot;c2FudGUubGVmaWdhcm8uZnJfXzFmMGI3ZTVmLTQ0ZmMtNjg1ZS04MjVjLTNkYjYyNjFlMmJkNV9fQXJ0aWNsZQ==_Cancer: sur la piste d\u2019une mol\u00e9cule contre les redoutables neuropathies provoqu\u00e9es par la chimioth\u00e9rapie_332&quot;, &quot;customIDSPE&quot;: &quot;c2FudGUubGVmaWdhcm8uZnJfXzFmMGI3ZTVmLTQ0ZmMtNjg1ZS04MjVjLTNkYjYyNjFlMmJkNV9fQXJ0aWNsZQ==&quot;, &quot;event&quot;: &quot;customEventSPE&quot;}\" target=\"_blank\" rel=\"noopener\"><br \/>\n                    Connectez-vous<br \/>\n                <\/a>\n            <\/p>\n","protected":false},"excerpt":{"rendered":"Les neuropathies chimio-induites sont provoqu\u00e9es par une atteinte des nerfs, qui se traduit principalement dans les pieds et&hellip;\n","protected":false},"author":2,"featured_media":513081,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[41338,63404,1011,27,72,63403,71],"class_list":{"0":"post-513080","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sante","8":"tag-cancer-presentation-generale","9":"tag-chimiotherapie-effets-generaux","10":"tag-fr","11":"tag-france","12":"tag-health","13":"tag-nerf","14":"tag-sante"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/115496099811219526","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/513080","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=513080"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/513080\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/513081"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=513080"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=513080"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=513080"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}